You are here

Alector

BioSpace's List of February 2019 Life Science IPOs

BioSpace's List of February 2019 Life Science IPOs

BioSpace

Shockwave Medical

Harpoon Therapeutics

Hoth Therapeutics

Flag link:

Alector IPO Banks $176M to Test Alzheimer’s Drugs in Clinical Trials

Alector IPO Banks $176M to Test Alzheimer’s Drugs in Clinical Trials

Xconomy

Alzheimer's disease

Flag link:

Immuno-Neurology Focused Alector Files $180 Million IPO

Immuno-Neurology Focused Alector Files $180 Million IPO

CP Wire

immuno-neurology

Flag link:

Immuno-Neurology Focused Alector Files $180 Million IPO

Flag link:

Alector Files for IPO to Fund Studies of Alzheimer’s, Dementia Drugs

Alector Files for IPO to Fund Studies of Alzheimer’s, Dementia Drugs

Xconomy

Alzheimer's disease

Flag link:

Four Healthcare Startups Raised Over $130 Million Last Month

Four Healthcare Startups Raised Over $130 Million Last Month

Forbes

Compass Therapeutics

Flag link:

AbbVie antes up $225M in cash to buy into the Alzheimer’s platform at Alector

AbbVie antes up $225M in cash to buy into the Alzheimer’s platform at Alector

Endpoints

Alzheimer's disease

Flag link:

The 2015 Fierce 15 biotech execs take a bow

The 2015 Fierce 15 biotech execs take a bow

Fierce Biotech

CRISPR Therapeutics

Intellia Therapeutics

NGM Biopharmaceuticals

Padlock Therapeutics

Revolution Medicines

Syros Pharmaceuticals

Unum Therapeutics

Yumanity Therapeutics

Flag link:

FierceBiotech's 2015 Fierce 15

FierceBiotech's 2015 Fierce 15

Fierce Biotech

CRISPR Therapeutics

Denali Therapeutics

Intellia Therapeutics

NGM Biopharmaceuticals

Padlock Therapeutics

Revolution Medicines SQZ Biotech

Surface Oncology

Syros Pharmaceuticals

Unum Therapeutics

Yumanity Therapeutics

Flag link:

J&J partners with a biotech start-up on a new approach to Alzheimer's

J&J partners with a biotech start-up on a new approach to Alzheimer's

Fierce Biotech

Alzheimer's disease

Flag link: